In Reply: Thank you to all who responded to
the joint editorial published by the ICMJE. I respond only for myself to the
3 authors whose representative letters appear in this issue of JAMA.
Ms Dresser addresses the advantage of a comprehensive trial registry
in raising public awareness that the purpose of clinical research is to advance
knowledge, not to provide the best treatment for participants. I submit that
the raised public awareness and the occasional successful treatment of patients
who volunteer for such studies are both secondary but welcome outcomes of
a clinical trial registry.
DeAngelis CD. Clinical Trial Registration and the ICMJE—Reply. JAMA. 2005;293(2):157–158. doi:10.1001/jama.293.2.158-a
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.